%0 Journal Article
%A 
%T The Role of Immune-Inflammation Biomarkers to Predict the Response of Nivolumab in Second Line Treatment of Advanced Stage Non-Small Cell Lung Cancer
%D 2024
%F 
%P 58-66
%V 8
%N 1
%R doi:10.14744/ejmi.2023.36214
%U https://dx.doi.org/10.14744/ejmi.2023.36214